Stephanie Manson

Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study

Marinus H. J. van Oers, Kazimierz Kuliczkowski, Lukáš Smolej et al. · The Lancet Oncology · 2015 · 112 citations

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +11

Health‐related quality‐of‐life results from PALETTE: A randomized, double‐blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

Corneel Coens, Winette T.A. van der Graaf, Jean‐Yves Blay et al. · Cancer · 2015 · 90 citations · Full text

Quantity determination and the distance effect with letters, numbers, and shapes: a functional MR imaging study of number processing.

Robert K. Fulbright, Stephanie Manson, Pawel Skudlarski et al. · PubMed · 2003 · 85 citations · Full text

Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy

Stephanie Manson, Jacqueline Palace, Joseph A. Frank et al. · Experimental Brain Research · 2006 · 67 citations

Callosum Atrophy, Neurobiology Of Disease, Neurological Disorder +12

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

Dirk Schadendorf, Axel Hauschild, Mario Santinami et al. · The Lancet Oncology · 2019 · 54 citations

High-risk Melanoma, Surgical Oncology, Oncology +9